The group’s principal activity is to convert liquids into vapor. The group converting liquids into vapor has significant cost, efficiency, and accuracy advantages over traditional techniques. The group's Capillary Force Vaporizer (CFV) is a disruptive technology enabling new generations of medical device, consumer product, drug delivery, and advanced energy products and systems. The group operates from the United States.
